Studies of populations in the USA or Europe have shown that BRCA1 and BRCA2 mutations have a 24–35% and 19–29% risk of developing contralateral breast cancer within 10 years of their first breast cancer [8, 31–33]. Here, BRCA2 is linked to breast cancer.